Literature DB >> 24690334

Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a QALY.

Erik Nord1, Rune Johansen2.   

Abstract

OBJECTIVE: In a wide range of health care jurisdictions, to give priority to the severely ill over the less severely ill is important in decisions about resource allocation across patient groups. We summarise data on concerns for severity measured at a cardinal level in preference studies in various countries and show how the data may provide guidance for determining severity graded willingness to pay for a QALY.
METHODS: We review evidence in 15 articles published in peer reviewed journals in the time period 1978-2010, with reports from altogether 20 individual studies in 9 different countries. The studies all focus on the quality of life dimension of severity, i.e. utility losses on the 0-1 scale used in QALY-calculations. We report 116 individual observations of paired comparisons of utility improvements with different start levels. We argue that the strength of concerns observed on the quality of life dimension may be assumed to apply also to losses in length of life and thus to severity in terms of proportional shortfall of QALYs. By means of regression analyses we estimate a severity gradient in each study that suggests the span in societal willingness to pay for a QALY to people at high and low levels of severity respectively.
RESULTS: Concerns for severity show up quite strongly across countries, sample types and question framings, although the size of the severity gradient varies very much. Interested policy makers may hopefully find the central tendency in the results to be useful as an input to determining severity dependent willingness to pay for a QALY.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Economic evaluation; Equity; Fairness; Proportional shortfall; QALY; Severity; Social value; Societal value; Utility; Willingness to pay

Mesh:

Year:  2014        PMID: 24690334     DOI: 10.1016/j.healthpol.2014.02.009

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  15 in total

1.  Cost-value analysis of health interventions: introduction and update on methods and preference data.

Authors:  Erik Nord
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

2.  Cost-Value Analysis and the SAVE: A Work in Progress, But an Option for Localised Decision Making?

Authors:  Jonathan Karnon; Andrew Partington
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

3.  Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss.

Authors:  Ulrikke J V Hernæs; Kjell A Johansson; Trygve Ottersen; Ole F Norheim
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

4.  Transforming EQ-5D utilities for use in cost–value analysis of health programs.

Authors:  Erik Nord; Rune Johansen
Journal:  Eur J Health Econ       Date:  2015-04

5.  Effectiveness and Cost of Organized Outreach for Colorectal Cancer Screening: A Randomized, Controlled Trial.

Authors:  Ma Somsouk; Carly Rachocki; Ajitha Mannalithara; Dianne Garcia; Victoria Laleau; Barbara Grimes; Rachel B Issaka; Ellen Chen; Eric Vittinghoff; Jean A Shapiro; Uri Ladabaum
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

6.  Beyond QALYs: Multi-criteria based estimation of maximum willingness to pay for health technologies.

Authors:  Erik Nord
Journal:  Eur J Health Econ       Date:  2017-03-03

7.  Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression.

Authors:  Christian R C Kouakou; Thomas G Poder
Journal:  Eur J Health Econ       Date:  2021-08-21

8.  How important is severity for the evaluation of health services: new evidence using the relative social willingness to pay instrument.

Authors:  Jeff Richardson; Angelo Iezzi; Aimee Maxwell
Journal:  Eur J Health Econ       Date:  2016-07-25

9.  Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings.

Authors:  Sarah E Rutstein; Joan T Price; Nora E Rosenberg; Stuart M Rennie; Andrea K Biddle; William C Miller
Journal:  Glob Public Health       Date:  2016-05-04

10.  Are all health gains equally important? An exploration of acceptable health as a reference point in health care priority setting.

Authors:  S Wouters; N J A van Exel; K I M Rohde; W B F Brouwer
Journal:  Health Qual Life Outcomes       Date:  2015-06-10       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.